GlassScriptPhysician profile
Ari Mintz
NPI 1386907715
$10,891.79
in general payments reported to CMS, 2019-2025
17 companies · $522 in 2025
The $522 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $213 · 2021: $82.86 · 2022: $147 · 2023: $3,124 · 2024: $6,346 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $2,360 · Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $2,359.74 |
| Food and Beverage | $1,631.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $8,543.76 | 2023-2024 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $917.89 | 2019-2025 | Interlock, 2cm Peripheral Cutting Balloon, Watchman Flx |
| Shockwave Medical, INC | $336.61 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $216.96 | 2019-2020 | |
| Abbott Laboratories | $213.71 | 2019-2023 | Amplatzer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.08 | 2022-2025 | Jardiance |
| Cagent Vascular INC | $116.63 | 2025 | Serrantor |
| Novartis Pharmaceuticals Corporation | $99.23 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $75.04 | 2021-2023 | Xarelto |
| Pfizer INC. | $52.58 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $35.00 | 2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $27.39 | 2022 | |
| Amgen INC. | $23.25 | 2021-2022 | |
| Bridgebio Pharma, INC. | $22.54 | 2025 | Attruby |
| Tactile Systems Technology INC | $20.77 | 2024 | Flexitouch Plus, Entre Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $20.16 | 2024 | Camzyos |
| Abiomed | $16.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Mintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.